INSYSBIO UK Limited - Period Ending 2024-03-31

INSYSBIO UK Limited - Period Ending 2024-03-31


INSYSBIO UK Limited SC600028 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is scientific research consulting Digita Accounts Production Advanced 6.30.9574.0 true true SC600028 2023-04-01 2024-03-31 SC600028 2024-03-31 SC600028 bus:OrdinaryShareClass1 2024-03-31 SC600028 core:RetainedEarningsAccumulatedLosses 2024-03-31 SC600028 core:ShareCapital 2024-03-31 SC600028 core:CurrentFinancialInstruments 2024-03-31 SC600028 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 SC600028 core:FurnitureFittingsToolsEquipment 2024-03-31 SC600028 bus:SmallEntities 2023-04-01 2024-03-31 SC600028 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 SC600028 bus:FilletedAccounts 2023-04-01 2024-03-31 SC600028 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 SC600028 bus:RegisteredOffice 2023-04-01 2024-03-31 SC600028 bus:Director1 2023-04-01 2024-03-31 SC600028 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 SC600028 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 SC600028 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 SC600028 core:PlantMachinery 2023-04-01 2024-03-31 SC600028 countries:Scotland 2023-04-01 2024-03-31 SC600028 2023-03-31 SC600028 core:FurnitureFittingsToolsEquipment 2023-03-31 SC600028 2022-04-01 2023-03-31 SC600028 2023-03-31 SC600028 bus:OrdinaryShareClass1 2023-03-31 SC600028 core:RetainedEarningsAccumulatedLosses 2023-03-31 SC600028 core:ShareCapital 2023-03-31 SC600028 core:CurrentFinancialInstruments 2023-03-31 SC600028 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 SC600028 core:FurnitureFittingsToolsEquipment 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: SC600028

INSYSBIO UK Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2024

 

INSYSBIO UK Limited

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 7

 

INSYSBIO UK Limited

Company Information

Director

Ms Galina Lebedeva

Registered office

17-19 East London Steet
Edinburgh
EH7 4BN

Accountants

Bond CA
17-19 East London Street
Edinburgh
EH7 4ZD

 

INSYSBIO UK Limited

(Registration number: SC600028)
Abridged Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

577

1,155

Current assets

 

Debtors

5

17,902

215,166

Cash at bank and in hand

 

710,887

306,836

 

728,789

522,002

Prepayments and accrued income

 

-

5,751

Creditors: Amounts falling due within one year

(85,534)

(103,322)

Net current assets

 

643,255

424,431

Total assets less current liabilities

 

643,832

425,586

Provisions for liabilities

(144)

-

Accruals and deferred income

 

(94,668)

(59,306)

Net assets

 

549,020

366,280

Capital and reserves

 

Called up share capital

6

1,000

1,000

Retained earnings

548,020

365,280

Shareholders' funds

 

549,020

366,280

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

 

INSYSBIO UK Limited

(Registration number: SC600028)
Abridged Balance Sheet as at 31 March 2024

Approved and authorised by the director on 14 June 2024
 

.........................................
Ms Galina Lebedeva
Director

 

INSYSBIO UK Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
17-19 East London Steet
Edinburgh
EH7 4BN
Scotland

These financial statements were authorised for issue by the director on 14 June 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts.

Revenue is recognised when it can be reliably measured and it is probable that future economic benefits will flow to the company.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

 

INSYSBIO UK Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Tax

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

33% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Share capital

Ordinary shares are classified as equity.

 

INSYSBIO UK Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2023

1,733

1,733

At 31 March 2024

1,733

1,733

Depreciation

At 1 April 2023

578

578

Charge for the year

578

578

At 31 March 2024

1,156

1,156

Carrying amount

At 31 March 2024

577

577

At 31 March 2023

1,155

1,155

5

Debtors

Debtors includes £Nil (2023 - £Nil) due after more than one year.

6

Share capital

Allotted, called up and fully paid shares

 

INSYSBIO UK Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

2024

2023

No.

£

No.

£

Ordinary shares of £10 each

100

1,000

100

1,000